Filing excerpt
At the 2026 annual meeting of shareholders of IDEXX Laboratories, Inc. (the “Corporation”) held on May 12, 2026 (the “Annual Meeting”), upon the recommendation of the Corporation’s Board of Directors (the “Board”), the Corporation’s shareholders approved amendments to the Corporation’s Amended and Restated Certificate of Incorporation to (i) declassify the Board over a three-year period and provide for the annual election of all directors beginning at the 2029 annual meeting of shareholders and (ii) provide for shareholders owning at least 25% of the shares of the Corporation’s capital stock continuously for at least one year the right to have the Corporation call a special meeting of shareholders...